Trexquant Investment LP Takes Position in Envista Holdings Co. (NYSE:NVST)

Trexquant Investment LP bought a new position in shares of Envista Holdings Co. (NYSE:NVST) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 310,124 shares of the company’s stock, valued at approximately $5,982,000. Trexquant Investment LP owned approximately 0.18% of Envista at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Envista during the fourth quarter worth about $53,000. Lecap Asset Management Ltd. purchased a new position in Envista in the fourth quarter worth approximately $281,000. Geode Capital Management LLC increased its position in shares of Envista by 2.5% in the 3rd quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company’s stock valued at $57,233,000 after purchasing an additional 71,435 shares during the last quarter. Hantz Financial Services Inc. raised its holdings in shares of Envista by 146.6% in the 4th quarter. Hantz Financial Services Inc. now owns 110,489 shares of the company’s stock valued at $2,131,000 after purchasing an additional 65,679 shares in the last quarter. Finally, Sanctuary Advisors LLC acquired a new stake in shares of Envista in the 3rd quarter valued at $228,000.

Analysts Set New Price Targets

A number of analysts have weighed in on NVST shares. JPMorgan Chase & Co. cut their price target on Envista from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Thursday, March 6th. UBS Group decreased their target price on Envista from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Monday, March 10th. Piper Sandler increased their price target on shares of Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a research note on Monday, February 3rd. Morgan Stanley reduced their price objective on shares of Envista from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Thursday, March 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research report on Thursday, March 6th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $20.18.

Envista Price Performance

Shares of NYSE:NVST opened at $15.47 on Friday. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The company has a 50-day moving average price of $19.18 and a 200 day moving average price of $19.52. Envista Holdings Co. has a 52 week low of $14.77 and a 52 week high of $23.00. The company has a market cap of $2.66 billion, a P/E ratio of -2.38, a PEG ratio of 1.27 and a beta of 1.12.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. Research analysts predict that Envista Holdings Co. will post 1 earnings per share for the current year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.